Doctors' Perspective on Tobacco Addiction

December 1, 2023 updated by: Olcay Ayçiçek, Karadeniz Technical University

Approaches of Doctors in Different Branches to the Smoking Habits of Their Patients; Patient's Perspective Survey Study

ABSTRACT

Aim:

Our study aimed to determine the approaches of our physicians to the smoking habits of their patients other than those with pulmonary diseases.

Method:

Patients examined in different outpatient clinics of our hospital will be asked 7 questions about the doctor's approach to smoking habits.

1) Do you have information about smoking cessation clinic? 2) Has your doctor asked if you smoke? 3) Did he suggest you stop using it? 4) Did he inform you about the relationship between smoking and your disease? 5) Did he provide information about smoking cessation outpatient clinic services? 6) Have you ever thought about quitting smoking after your doctor's briefing? 7) Did you quit smoking after your doctor's briefing?

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

  1. INTRODUCTION:

    Tobacco use can cause many health problems with both its direct effects on all systems and passive smoke exposure (1). Tobacco use is very common in the world and ranks second among the most common causes of death. According to the World Health Organization, 20.2% of people aged 15 and over smoke and more than 8 million people die each year from active smoking. The mortality rates due to passive smoking are too high to be underestimated, and approximately 1.2 million people are lost due to health problems and second-hand smoke exposure (2).

    The prevalence of tobacco use among adults (aged 15 and over) is 31.2% (48% in men and 15% in women). Regular smoking is especially common between the ages of 25-44. Studies show that smoking rates in Turkey are inversely proportional to the level of education (3).

    Physicians are the most influential ones on tobacco use behavior. Informing patients about tobacco addiction, helping with treatment, and drawing a sample profile by not using tobacco is a profile that every physician should portray. Today, smoking cessation support is provided by specialist physicians (Chest diseases, Family medicine) to help smokers quit. In this process, patients are supported with both behavioral treatment and medical treatment (4-5). However, this support should not be limited to the specified sections. The physician evaluating a patient should contribute to tobacco control regardless of his/her branch, learn whether the patient is using tobacco or not, advise the patient to quit if he/she is using it, and should inform and direct the patient from smoking cessation outpatient clinics.

    In this study, it is aimed to evaluate the attitudes and habits of our physicians working in non-chest disease departments in our hospital and to determine their role in developing a positive attitude towards patients. With the results of the study, it is aimed to question the smoking habits of physicians in patients, to be a guide and leader, to reveal the differences in physician approaches according to branches, to be a guide for initiatives to increase positive attitudes by analyzing positive and negative results and self-criticism.

  2. MATERIALS-METHODS:

The study will start after the approval of the faculty ethics committee. Patients who were examined in other branch outpatient clinics other than the chest diseases department of our hospital will questioned for 3 months. Those who did not volunteer to participate in the survey, patients under the age of 18, and patients whose mental status was not suitable for the survey will not included in the study. As the place where the questionnaire will be conducted, the blood collection laboratory where all the patients come mostly was chosen, and the patients who came here to donate blood were randomly selected and the questionnaire was conducted. In addition to their demographic characteristics, the following 7 questions were asked to the patients. 1) Do you know about smoking cessation outpatient clinic? 2) Has your doctor asked if you smoke? 3) Has he suggested you stop using it? 4) Has he informed you about the relationship of smoking with your illness? 5) Has s/he informed about smoking cessation outpatient clinic services? 6) Have you ever considered quitting smoking after your doctor's briefings? 7) Have you quitted smoking after your doctor's briefings? The responses will compared according to the branches.

It will investigated whether the patients asked the questions specified in the data form about their demographic characteristics, educational status, diagnosis, the branch they were examined in, the recommendations of the examining physician regarding the patient's smoking habit and whether they quit if they smoked.

2.1.Statistical Analysis The suitability of the data for normal distribution will examined with the ShapiroWilk and Kolmogorog Smirnov tests. Kruskall-Wallis, Mann-Whitney U, student-t and chi-square tests will used for intergroup comparisons. General linner modeling, Wilcowon and Friedman tests will used in serial follow-up data. Data will presented as percentage, mean (std deviation) and median (minimum-maximum). Pearson's chi-square test will used to compare the qualitative data. Categorical data will presented as frequency and percentage.

Study Type

Observational

Enrollment (Actual)

941

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Trabzon, Turkey, 61100
        • Department of Chest Diseases, Division Of Intensive Care Medicine, Faculty of Medicine, Karadeniz Technical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients who were examined in other branch outpatient clinics other than the chest diseases department of our hospital

Description

Inclusion Criteria:

- Patients who were examined in other branch outpatient clinics other than the chest diseases department of our hospital

Exclusion Criteria:

  • Those who did not volunteer to participate in the survey
  • Patients under the age of 18
  • patients whose mental status was not suitable for the survey

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nicotine addiction
Time Frame: 3 month
Determining how effective doctors working in branches other than pulmonology are in helping smokers quit smoking.
3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Merve Ozdogan Algın, MD, Karadeniz Technical University Faculty of Medicine Department of Chest disease
  • Study Chair: Ensar Cihad Emiroglu, MD, Karadeniz Technical University Faculty of Medicine Department of Chest disease
  • Study Chair: Funda Oztuna, Proff, Karadeniz Technical University Faculty of Medicine Department of Chest disease

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

July 30, 2023

Study Completion (Actual)

September 30, 2023

Study Registration Dates

First Submitted

October 3, 2023

First Submitted That Met QC Criteria

December 1, 2023

First Posted (Estimated)

December 11, 2023

Study Record Updates

Last Update Posted (Estimated)

December 11, 2023

Last Update Submitted That Met QC Criteria

December 1, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Protocol No: 2022/143

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nicotine Dependence

Clinical Trials on survey study

Subscribe